Bo Baslund

5.2k total citations
72 papers, 2.8k citations indexed

About

Bo Baslund is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Bo Baslund has authored 72 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 24 papers in Rheumatology and 20 papers in Physiology. Recurrent topics in Bo Baslund's work include Vasculitis and related conditions (34 papers), Sarcoidosis and Beryllium Toxicity Research (19 papers) and Systemic Lupus Erythematosus Research (7 papers). Bo Baslund is often cited by papers focused on Vasculitis and related conditions (34 papers), Sarcoidosis and Beryllium Toxicity Research (19 papers) and Systemic Lupus Erythematosus Research (7 papers). Bo Baslund collaborates with scholars based in Denmark, Sweden and United States. Bo Baslund's co-authors include Mikkel Faurschou, Niels Graudal, Gesche Jürgens, B. Thomsen, Michael H. Alderman, Lene Mellemkjær, N. Tvede, Inge Juul Sørensen, Jörgen Wieslander and Bente Klarlund Pedersen and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Journal of Applied Physiology.

In The Last Decade

Bo Baslund

71 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bo Baslund Denmark	32	1.2k	929	613	538	425	72	2.8k
Pieter C. Limburg Netherlands	38	1.1k 1.0×	1.2k 1.3×	1.7k 2.8×	360 0.7×	280 0.7×	79	3.8k
Gideon Nesher Israel	30	1.3k 1.1×	1.4k 1.6×	388 0.6×	175 0.3×	424 1.0×	107	2.8k
Shouichi Fujimoto Japan	27	829 0.7×	337 0.4×	180 0.3×	284 0.5×	330 0.8×	81	2.0k
Manuela Födinger Austria	32	230 0.2×	1.3k 1.4×	916 1.5×	334 0.6×	268 0.6×	117	3.0k
A Meyrier France	34	1.0k 0.9×	579 0.6×	488 0.8×	246 0.5×	287 0.7×	155	3.9k
Matija Tomšič Slovenia	28	555 0.5×	1.7k 1.9×	627 1.0×	209 0.4×	441 1.0×	131	2.8k
Jean‐François Schved France	39	440 0.4×	354 0.4×	317 0.5×	142 0.3×	784 1.8×	209	4.7k
Paola Caramaschi Italy	31	614 0.5×	909 1.0×	615 1.0×	209 0.4×	118 0.3×	144	2.9k
Yoshifumi Ubara Japan	29	826 0.7×	616 0.7×	210 0.3×	293 0.5×	106 0.2×	366	3.6k
José Luís Callejas-Rubio Spain	27	426 0.4×	1.0k 1.1×	722 1.2×	248 0.5×	108 0.3×	143	2.2k

Countries citing papers authored by Bo Baslund

Since Specialization

Citations

This map shows the geographic impact of Bo Baslund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Baslund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Baslund more than expected).

Fields of papers citing papers by Bo Baslund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Baslund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Baslund. The network helps show where Bo Baslund may publish in the future.

Co-authorship network of co-authors of Bo Baslund

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Baslund. A scholar is included among the top collaborators of Bo Baslund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Baslund. Bo Baslund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leffers, Henrik, Bo Baslund, Jesper Lindhardsen, Sophine Boysen Krintel, & Niels Graudal. (2024). Abatacept and tofacitinib in refractory sarcoidosis: drug survival, safety, and treatment response. Clinical and Experimental Rheumatology. 42(11). 2167–2174. 1 indexed citations

Therkildsen, Philip, Annette de Thurah, Berit Dalsgaard Nielsen, et al.. (2024). The one-year infection risk among patients diagnosed with giant cell arteritis: use of antibiotics and hospitalisations. Lara D. Veeken. 64(2). 740–746. 2 indexed citations

Sun, Guoli, Adelina Yafasova, Bo Baslund, et al.. (2021). Long-term Risk of Heart Failure and Other Adverse Cardiovascular Outcomes in Granulomatosis With Polyangiitis: A Nationwide Cohort Study. The Journal of Rheumatology. 49(3). 291–298. 6 indexed citations

Yafasova, Adelina, Emil Loldrup Fosbøl, Morten Schou, et al.. (2021). Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus. Journal of the American College of Cardiology. 77(14). 1717–1727. 54 indexed citations

Faurschou, Mikkel, Lars Haukali Omland, Niels Obel, Jesper Lindhardsen, & Bo Baslund. (2021). Risk of Cancer Among Sarcoidosis Patients With Biopsy-verified Nonnecrotizing Granulomatous Inflammation: Population-based Cohort Study. The Journal of Rheumatology. 49(2). 186–191. 8 indexed citations

Faurschou, Mikkel, Magnus Glindvad Ahlström, Jesper Lindhardsen, Bo Baslund, & Niels Obel. (2015). Impact of pre-existing co-morbidities on mortality in granulomatosis with polyangiitis: a cohort study. Lara D. Veeken. 55(4). 649–653. 13 indexed citations

Baslund, Bo, Marie Helleberg, Mikkel Faurschou, & Niels Obel. (2014). Mortality in patients with giant cell arteritis. Lara D. Veeken. 54(1). 139–143. 45 indexed citations

Milman, Nils, Niels Graudal, Annika Loft, et al.. (2011). Effect of the TNF‐α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG‐PET. The Clinical Respiratory Journal. 6(4). 238–247. 58 indexed citations

Suppiah, Ravi, Chetan Mukhtyar, Federico Alberici, et al.. (2010). MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA). Oxford University Research Archive (ORA) (University of Oxford). 4 indexed citations

10.

Suppiah, Ravi, Chetan Mukhtyar, Oliver Floßmann, et al.. (2010). A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Lara D. Veeken. 50(5). 899–905. 76 indexed citations

11.

Østergaard, Mikkel, Bo Baslund, William F. C. Rigby, et al.. (2010). Ofatumumab, a human anti‐CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease‐modifying antirheumatic drugs: Results of a randomized, double‐blind, placebo‐controlled, phase I/II study. Arthritis & Rheumatism. 62(8). 2227–2238. 74 indexed citations

12.

Faurschou, Mikkel, Lene Mellemkjær, Inge Juul Sørensen, et al.. (2009). Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis. Arthritis & Rheumatism. 60(4). 1187–1192. 111 indexed citations

13.

Floßmann, Oliver, Bo Baslund, Annette Bruchfeld, et al.. (2008). Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. Annals of the Rheumatic Diseases. 68(7). 1125–1130. 63 indexed citations

14.

Krogh‐Madsen, Rikke, et al.. (2007). Insulin resistance in patients with rheumatoid arthritis: effect of anti‐TNFα therapy. Scandinavian Journal of Rheumatology. 36(2). 91–96. 82 indexed citations

15.

Baslund, Bo, N. Tvede, Bente Danneskiold‐Samsøe, et al.. (2005). Targeting interleukin‐15 in patients with rheumatoid arthritis: A proof‐of‐concept study. Arthritis & Rheumatism. 52(9). 2686–2692. 217 indexed citations

16.

Westman, Kerstin, Daina Selga, Per Bygren, et al.. (1998). Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody: Technical Note. Kidney International. 53(5). 1230–1236. 78 indexed citations

17.

Baslund, Bo, Wladimir Szpirt, Sten Eriksson, et al.. (1996). Complexes between proteinase 3, α₁‐antitrypsin and proteinase 3 anti‐neutrophil cytoplasm autoantibodies: a comparison between α₁‐antitrypsin PiZ allele carriers and non‐carriers with Wegener's granulomatosis. European Journal of Clinical Investigation. 26(9). 786–792. 26 indexed citations

18.

Wiik, Allan, et al.. (1995). Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity — A methodological study. Journal of Immunological Methods. 187(2). 287–295. 19 indexed citations

19.

Baslund, Bo & Jörgen Wieslander. (1994). A rapid and semi-quantitative method for the detection of autoantibodies by multiple spot immunoassay. Journal of Immunological Methods. 169(2). 183–193. 10 indexed citations

20.

Baslund, Bo, Jørgen Holm Petersen, Henrik Permin, Allan Wiik, & Jörgen Wieslander. (1994). Measurements of proteinase 3 and its complexes with α1-proteinase inhibitor and Anti-Neutrophil Cytoplasm Antibodies (ANCA) in plasma. Journal of Immunological Methods. 175(2). 215–225. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact